BEY2153
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BEY2153, covering 2025-03-10 to 2025-03-20. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Efficacy of BEY2153 in Patients with Early Alzheimer's Disease [Phase 2]